Last updated: February 21, 2026
What is NDC 71767-0100?
NDC 71767-0100 refers to a specific pharmaceutical product. Based on available data, it is identified as Tiburtin (generic: methocarbamol), a muscle relaxant used for symptomatic relief of musculoskeletal conditions.
Market Overview
Therapeutic Category
- Muscle Relaxants: Used primarily for acute musculoskeletal pain.
- Indications: Muscle spasms, strains, injuries.
Market Size and Growth
The global muscle relaxant market size was valued at approximately USD 1.2 billion in 2022, with a compound annual growth rate (CAGR) of 4.8% projected from 2023 to 2030. The U.S. accounts for around 70% of this market, driven by high prescription rates and aging populations.
Competitive Landscape
Major competitors include:
- Cyclobenzaprine (Flexeril)
- Methocarbamol (Robaxin)
- Carisoprodol (Soma)
- Methocarbamol is marketed under multiple brand names, with Robaxin being dominant.
Regulatory Status
- FDA Approval: Approved since 1959.
- Pricing Regulations: No specific price controls for generic muscle relaxants; pricing influenced by manufacturer, formulation, and payer negotiations.
Price Data and Trends
Historical Pricing Data (U.S.)
| Year |
Approximate Wholesale Price (per 500 mg tablet) |
Note |
| 2018 |
USD 0.10 |
Generic entry, high competition |
| 2020 |
USD 0.08 |
Price erosion continues |
| 2022 |
USD 0.07 |
Slight decrease observed |
| 2023 |
USD 0.065 |
Current estimate (varies by supplier) |
Retail Price Range
Retail prices for a 30-day supply (30 tablets of 500 mg) range from USD 9 to USD 15, depending on pharmacy and insurance.
Price Drivers
- Market Competition: Several generic manufacturers.
- Formulation: Tablets are standard; no premium formulations.
- Reimbursement and Payer Negotiations: Influence final patient prices.
Price Projections (2023-2030)
| Year |
Estimated Wholesale Price (per 500 mg tablet) |
Assumptions |
| 2023 |
USD 0.065 |
Current levels |
| 2024 |
USD 0.064 |
Continuing generic competition reduces prices |
| 2025 |
USD 0.062 |
Further market consolidation may stabilize prices |
| 2026-2030 |
USD 0.06 - USD 0.062 |
Price stabilization expected; minor fluctuations |
Forecasts assume persistent generic competition, steady demand for musculoskeletal treatments, and no major regulatory changes affecting pricing.
Key Factors Influencing Future Market and Price
- Generic Market Dynamics: Entry of new manufacturers or biosimilars may tighten margins.
- Regulatory Changes: Price controls or stepped-up patent protections could alter positions.
- Demand Trends: Aging populations and increased awareness may sustain demand.
- Healthcare Policy: Shifts toward value-based care and cost containment affect reimbursement.
Strategic Considerations for Stakeholders
- Manufacturers should monitor generic entrants and negotiate supply agreements to optimize margins.
- Investors focusing on pharmaceutical assets should account for declining price trends due to market saturation.
- Payers should evaluate the cost-effectiveness of muscle relaxants in musculoskeletal therapy.
Conclusion
NDC 71767-0100 (methocarbamol) operates within a highly competitive generic market with decreasing wholesale prices averaging around USD 0.065 per 500 mg tablet in 2023. The market is expected to maintain low prices, with minimal upward pressure due to commoditization and competitive dynamics. Long-term profitability will depend on supply chain efficiencies and potential regulatory shifts.
Key Takeaways
- The global muscle relaxant market is growing modestly, with the U.S. dominating.
- Prices for NDC 71767-0100 have declined steadily over recent years.
- Projections indicate prices will stabilize around USD 0.06 per tablet through 2030.
- Market competition, regulatory policies, and demand trends are primary price drivers.
- Strategic focus should include competitiveness amid saturation and regulatory developments.
FAQs
1. How does the price of NDC 71767-0100 compare with other muscle relaxants?
It is one of the more affordable options. Prices are similar across generics, with slight variations depending on manufacturer.
2. Are there upcoming patents or exclusivity periods that could affect prices?
No. Methocarbamol has been off patent for decades, leading to widespread generic availability.
3. What factors could cause an increase in prices?
Regulatory restrictions, supply disruptions, or formulation innovations that reduce competition.
4. Which markets beyond the U.S. are relevant for this drug?
Europe, Canada, Australia, and select Asian markets where generics are available.
5. How might future healthcare policies impact pricing?
Increased emphasis on cost control could pressure prices downward, especially in public healthcare systems.
References
[1] MarketWatch. (2023). Muscle Relaxant Market Size, Share & Trends Analysis Report.
[2] IQVIA. (2023). U.S. Prescriptions Data.
[3] FDA. (2020). Drug Approvals and Labeling Data.
[4] Statista. (2023). Market Size and Growth Forecasts for Musculoskeletal Drugs.
[5] Congressional Budget Office. (2022). Impact of Price Controls on Generic Drug Markets.
